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ABSTRACT OF DISSERTATION
EXECUTIVE DEFICITS IN AMYOTROPHIC LATERAL SCLEROSIS: EXAMINING THE
CONSEQUENCES OF SELF-REGULATORY IMPAIRMENT ON QUALITY OF LIFE
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease that attacks
the motor system and contributes to a range of cognitive and behavioral impairments (e.g.,
behavioral and emotional disinhibition, planning and problem solving difficulties, impulsivity,
attention, and personality change). This executive dysfunction may contribute to selfregulatory impairment across several domains, including cognitive skills, thought processes,
emotion regulation, interpersonal skills, and physiology, that may be crucial to the quality of
life (QOL), or well being, of patients and their caregivers. Given the relentless course and
prognosis of ALS, palliative treatments for ALS should target the full range of self-regulatory
deficits. Thirty-seven patient-caregiver pairs completed questionnaires regarding the patients’
ability to regulate emotions, social behavior, and thought patterns. Patients also completed
neuropsychological measures of executive functions and provided measures of glycosylated
hemoglobin (A1c) and heart rate variability (HRV). Results suggest that SR and EF deficits
exist on a continuum in ALS, such that some patients evidence adequate or superior ability to
self-regulate while others evidence deficits. Patient- caregiver agreement about patients’ selfregulatory capacity across domains was generally weak to moderate. Patients perceived
themselves to have less capacity for global regulation than caregivers perceived them to have,
patients perceived less dyadic cohesion than caregivers, and patients perceived themselves to
ruminate more than caregivers indicated. Overall, caregivers tended to perceive a more
pervasive pattern of deficits compared to patients. Additionally, measures of SR and EF were
not strongly inter-correlated in general, challenging the idea that SR in different domains
depends on a common resource. Accordingly, correlations among measures of theoretically
similar constructs (i.e., EF and SR) were small to moderate in magnitude and non-significant.
With regard to physiological functioning, when patients had better regulated glucose (A1c),
patients and caregivers perceived better global regulation. A similar pattern emerged with
patient ratings, with higher baseline HRV linked to less emotional lability. Last, mixed results
were obtained when predicting patient and caregiver QOL. Less rumination, less dyadic
cohesion and more social anxiety were associated with higher QOL for patients. Caregivers’
QOL was not significantly related to their perceptions of patients’ self-regulatory capacity in
any area.
Keywords: Amyotropic Lateral Sclerosis (ALS), Self-Regulation, Executive Functioning,
Quality of Life, Heart Rate Variability.
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Chapter One
Introduction
Amyotrophic Lateral Sclerosis (ALS) is a progressive and invariably fatal
neurodegenerative disease with few options for treatment and no cure. Most people with ALS
die within 5 years of the onset of a host of motor symptoms including muscle atrophy and
cramps, spasticity, fasciculations, progressive motor weakness, and eventual paralysis. The
effects of ALS, however, are often not contained to the motor system, and may include some
degree of cognitive and behavioral impairment typically believed to be associated with frontal
lobe dysfunction, such as behavioral and emotional disinhibition, planning and problem
solving difficulties, impulsivity, attention, and personality change (Neary, Snowden, Mann,
Northern, Goulding, & Macdermott, 1990). However, rapid physical deterioration may
overshadow ALS patients’ cognitive deficits (Irwin, Lippa, & Swearer, 2007), which may
range from subtle to severe. Furthermore, these deficits may be related to problematic
behaviors and thoughts across domains important to functioning. Consequently, there is a
need to clarify the prevalence and pattern of cognitive and behavioral deficits in ALS, which
have a sizeable impact not only on the patients’ physical health and survival, but also on their
sense of well being, or quality of life (QOL), as they approach the end of life.
What is ALS?
Amyotrophic Lateral Sclerosis (ALS) is a motor neuron disease affecting
approximately 30,000 people in the United States (ALS Association, 2004) that involves the
progressive degeneration of upper and lower motor neurons, leading to muscle weakening and
wasting, eventual paralysis, and death (commonly from respiratory failure) (NINDS, 2003).
ALS comprises one major subtype of Motor Neuron Diseases (MND), which encompasses the
group of neurological disorders involving disrupted communication between nerve cells in the
1

brain and those in the spinal cord. Although ALS is synonymous with MND in North America
and continental Europe (Bak, O’Donovan, Xuereb, Boniface, & Hodges, 2001; Goldstein,
Atkins, & Leigh, 2002; NINDS, 2009), there are various subtypes of MND, based primarily on
the site of motor neuron degeneration. In particular, Primary Lateral Sclerosis (PLS), which is
considered a variant of ALS, initially affects only upper motor neurons and typically has a
slower rate of progression (NINDS, 2009). Much research on MND however, encompasses
individuals with MND in general, or does not specify the subtype(s) included in the sample.
In fact, some experts suggest that ALS and PLS could be 2 points on a continuum of MND,
and not distinct disorders (Tartaglia, Rowe, Findlater, Orange, Grace, & Strong, 2007).
Therefore, throughout this paper, the term ALS will be inclusive of other subtypes of MND
(i.e., PLS).
No cure exists for ALS, and treatment options are similarly limited for both ALS and
PLS. Although ALS has a more relentless course than PLS and is often fatal, up to 10% of
people with ALS may survive up to 10 years after symptom onset (ALS Association, 2004).
On the other hand, PLS is not fatal and advances much slower (NINDS, 2009). This
highlights the need to examine the complete scope and trajectory of the disease course as well
as psychological and personality factors that may influence patients’ treatment compliance,
survival, and psychological well being, as well as that of the person providing their care.
Cognitive Functioning in ALS
Although originally conceptualized as a purely motor disease, ALS is increasingly
recognized as a multi-system disorder (Strong, 2001, 2008; Strong & Rosenfeld, 2003) that is
“recognized to include cognitive impairment” (Wilson, Grace, Munoz, He, & Strong, 2001).
However, how to best conceptualize the range and scope of extra-motor deficits in ALS
remains a topic of debate. It is clear that not all people with ALS have severe cognitive and
2

behavioral impairment, and thus it is increasingly believed that people with ALS “with and
without cognitive impairment represent a disease continuum” (Ringholz, Appel, Bradshaw,
Cooke, Mosnik, & Schulz, 2005, p. 589; Yang, Sopper, Leystra-Lantz, & Strong, 2003).
Evidence that up to 50% of ALS patients exhibit mild cognitive impairment (Lomen-Hoerth,
Murphy, Lagmore, Kramer, Olney, & Miller, 2003; Massman, Sims, Cooke, Haverkamp, &
Appel, 1996; Ringholz et al., 2005) and approximately 15% of people with ALS meet criteria
for frontotemporal dementia1 (FTD; Barson, Kinsella, Ong, & Mathers, 2000; Neary,
Snowden, & Mann, 2000) suggests that cognitive decline may be a progressive feature of ALS
(Ringholz et al., 2005), such that some degree of cognitive problems precedes more obvious
motor impairments (Robinson, Lacey, Grugan, Glosser, Grossman, & McCluskey, 2006;
Schriber et al., 2005), making the issue of cognitive impairment in ALS potentially relevant to
all people with ALS. Therefore, limiting the scope of interest to extensive impairment is
dangerous for people with ALS who have less pronounced or sub-threshold deficits in domains
critical to their functioning that affect treatment compliance, quality of life, and survival (Irwin
et al., 2007; Olney et al., 2005).
While the prevalence of extra-motor impairment in ALS remains an area of debate, the
most consistent pattern of cognitive and behavioral deficits target language skills (e.g., verbal
fluency) and executive functions (EF) as measured by tasks of planning and problem solving
abilities, inhibition, attention, cognitive flexibility, and verbal and non-verbal fluency
(Abrahams, Leigh, Harvey, Vythelingum, Grise, & Goldstein, 2000; David & Gillum, 1986;

1

FTD involves frontal and temporal lobe atrophy and is characterized by pathological changes in

language, perception, motor skills, memory, planning, behavior, and performance quality (Neary &
Snowden, 1996).
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Frank, Haas, Heinze, Stark, & Munte, 1997; Irwin et al., 2007; Massman et al., 1996; Strong,
Grace, Orange, Leeper, Menon, & Aere, 1999; Talbot, Goulding, Lloyd, Snowden, Neary, &
Testa, 1995).
Executive Functions
Executive functions (EF) refer to a “wide range of cognitive processes and behavioral
competencies which include verbal reasoning, problem-solving, planning, sequencing, the
ability to sustain attention, resistance to interference, utilization of feedback, multi-tasking,
cognitive flexibility, and the ability to deal with novelty” (Chan, Shum, Toulopoulou, & Chen,
2008, p. 201). Although there is general agreement that ‘executive functions’ is a non-unitary
concept (Godefroy, Cabaret, Petit-Chenal, Pruvo, & Rousseaux, 1999) that enables the
“control and regulation of lower-level cognitive processes and goal-directed, future-oriented
behavior” (Alvarez & Emory, 2006, p. 17), there is less agreement regarding the best way to
decompose ‘executive functions’ into sub-constructs (e.g., initiating, inhibiting, switching).
Given that “a compelling theory of executive functions” is lacking (Miyake, Freidman,
Emerson, Witzki, Howerter, & Wager, 2000, p. 50) and the absence of a gold-standard
conceptualization of EF (Aron, 2008), studying EF can be difficult. This theoretical ambiguity
likely contributes to another difficulty with research on EF- “the lack of a clear gold standard
measure against which putative EF measures can be compared” (Royall et al., 2002, p. 381).
First, although ‘executive’ and ‘frontal lobe’ tasks are often used interchangeably, “the use of
executive function tests as ‘frontal lobe indicators’ is not warranted by the data” (Alvarez &
Emory, 2006, p. 32). While the frontal lobes may participate in functions deemed as
‘executive’, other brain regions are also important to EF. Second, most evidence suggests that
measures of EF have low reliability and low intercorrelations (Alvarez & Emory, 2006;
Miyake et al., 2000), which is not surprising if measures of ‘sub-constructs’ are compared.
4

Thus, the heterogeneous nature of EF suggests that quantifying EF using measures
conceptualized at a higher level (as opposed to sub-construct level) might be unhelpful.
One useful model of EF is Damasio’s (1995) somatic marker hypothesis, which
distinguishes between logically-driven (“cold” functions) and emotionally-driven (“hot”
functions) decision making (Bechara, Damasio, & Damasio, 2000). Specifically, the “cold”
component of EF enables activities such as planning, sequencing, utilization of feedback,
multi-tasking, cognitive flexibility that are incorporated in traditional conceptualizations of
EF. Conversely, the “hot” components of EF involve emotional arousal, beliefs, and
“regulation of one’s own social behavior” (Chan et al., 2008, p. 201). Thus, emotionally
triggered decision making is considered a “hot” function. It is likely that these “hot” and cool”
functions are mediated by related, but different regions of the brain (Bechara et al., 2000;
Owen, McMillan, Laird, & Bullmore, 2005). Evidence for this hypothesis is largely derived
from the Iowa Gambling Task (IGT; Bechara, Damasio, Damasio, & Andersen, 1994), a task
that assesses real-life decision making with regard to reward, punishment, and uncertainty.
The IGT is considered more “ecologically valid” than traditional measures of EF (e.g.,
Wisconsin Card Sorting Test), as it adopts a more contextual and behavioral approach to
examining EF in settings representative of “real-world” situations (Alvarez & Emory, 2006;
Manchester, Priestly, & Jackson, 2004; Ready, Stierman, & Paulsen, 2001). Thus, it is
thought to better reflect “the nature of impaired executive functioning in everyday life” than
standard neuropsychological tests that automatically control the environment (e.g., noise,
distractions), direct behavior (e.g., prompting and stopping behavior), and limit affective
arousal (Alvarez & Emory, 2006, p.1068; Manchester et al., 2004).

5

Executive Functions and Self-Regulation
There is general agreement, however, that EF broadly defined “control and regulate
thought and action” (Friedman, Miyake, Corley, Young, DeFries, & Hewitt, 2006, p. 172),
“enable us to formulate goals and plans” (Aron, 2007, p. 124), and are important to
“independent and responsible social behavior” (Lezak, 1993, p. 30). Likewise, self-regulation
(SR) is “the ability to control or override one’s thoughts, emotions, urges, and behavior” and
refers to processes that enable adaptive behavior and “flexibility necessary for…goal
attainment” (Galliot et al., 2007, p. 325).
Both of these control resources are limited and can be exhausted, resulting in problems
in controlling and regulating behavior and difficulty functioning in everyday life (Baumeister,
Bratslavsky, Muraven, & Tice, 1998; Galliot et al., 2007; Marios & Ivanhoff, 2005; Miyake et
al., 2000; Schmeichel, 2007; Vohs, Baumeister, & Ciarocco, 2005). On the other hand, both
can also be strengthened or enhanced through practice (Davidson, Zacks, & Williams, 2003;
Muraven, Baumeister, & Tice, 1999; Oaten & Cheng, 2006). Successful SR and executive
control have positive outcomes (e.g., more effective coping skills, superior academic
performance, less susceptibility to substance abuse, and reduced aggression; Galliot et al.,
2007).
Although there are conceptual similarities between EF and SR (Kaplan & Brown,
2010), they are often measured differently. Specifically, EF is relatively content-free, often
referring to unpracticed ability to perform cognitive operations (as measured by standard
neuropsychological tests). SR, on the other hand, is a content-rich, practiced function that
gains meaning when interpreted within the context of real-life situations. Thus, EF likely
contributes to the ability to self-regulate in various situations. Accordingly, Schmeichel (2007,
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p. 251) suggests that “depleted self-regulatory resources may more precisely be considered
instances of reduced resources for executive control”.
Self-Regulatory Challenges in ALS
Although standard neuropsychological tests of EF may highlight cognitive deficits in
ALS (e.g., FTD), there may be evidence of impairment in equally important areas, such as
emotion regulation, social regulation, and the regulation of thought processes.
Emotional
According to Gross (1998), emotion regulation “refers to the processes by which
individuals influence which emotions they have, when they have them, and how they
experience and express these emotions” (p. 275). Thus, emotion regulation is conceptualized
as a self-regulatory capacity that “involves the initiation of new, or the alteration of ongoing,
emotional response through the act of regulatory processes” (Oschner & Gross, 2005, p. 242).
Successful SR of emotions may depend on executive control, which is supported by evidence
that the brain circuitry involved in the control of emotions overlaps with that involved in
cognitive tasks measuring EF (Rule, Shimamura, & Knight, 2002; Taylor, Burkland,
Eisenberger, Lehman, Hilmert, & Lieberman, 2008). For example, inhibition likely
contributes to successful performance on cognitive tasks (e.g., WCST) as well as the
regulation of emotional expression.
Emotion regulation is particularly relevant in ALS. Up to half of the people with ALS
experience “sudden episodes of emotional display or pathologic laughing and crying (PLC)”
(McCullagh, Moore, Gawel, & Feinstein, 1999, p. 43). Even more, ALS patients with PLC
performed significantly worse than ALS patients without PLC on the WCST (McCullagh et
al., 1999). Mood disturbances (e.g., depression, anxiety) may also be viewed as a failure to
regulate emotions. Some research suggests that negative affect is common in people with ALS
7

(Tedman, Young, & Williams, 1997) with 44% to 75% of patients with ALS having
observable depression (Hogg, Goldstein, & Leigh, 1994; Tedman et al., 1997), and up to 42%
of patients having anxiety in the medium to high ranges (Wicks, Abrahams, Masi, HejdaForde, Leigh, & Goldstein, 2007). However, more recent evidence proposes that people with
ALS have minimal or mild symptoms of depression (Gauthier et al., 2007; Kilani et al., 2004;
Rabkin et al., 2005). In sum, not all people with ALS exhibit grossly inappropriate emotional
responses, which suggests that self-regulatory capacity to regulate one’s behavior and
emotions may be an individual difference. Hence, examining the range of these impairments
as well as their impact on patient and caregiver well being is important.
Social
Social interactions, including benign interactions such as coordinating interpersonal
efforts (e.g., to solve a problem; Finkel, Campbell, Brunell, Dalton, Scarbeck, & Chartrand,
2006), rely on self-regulatory capacity. Furthermore, reduced self-regulatory resources result
in passivity in social interactions. Other research indicates that low-anxious, socially active
people can expend the resources needed to overcome this passivity, but socially anxious
people do not have these self-regulatory resources upon which to draw (Baumeister, Gailliot,
DeWall, & Oaten, 2006).
Social relationships and support, albeit linked to high QOL in people with ALS
(Simmons, Bremer, Robbins, Walsh, & Fischer, 2000), may require a great deal of SR to
maintain. First, problems with communication (e.g., dysarthria; Strong, Grace, Orange, &
Leeper, 1996), reduced verbal output, and eventual mutism (Bak et al., 2001) may limit social
interactions. Next, behaving in a socially appropriate way requires reasonably intact cognitive
functions (e.g., attention, memory) and emotional control. In fact, caregivers report that some
patients “do not seem to understand or care about the feelings of others” (Grossman, Woolley8

Levine, Bradley, & Miller, 2007, p. 56). Altered social conduct in ALS is sometimes
characterized by over-activity and unrestrained behaviors (e.g., “inappropriate disrobing,
touching of staff, and/or inappropriate jokes”; Lomen-Hoerth et al., 2003, p. 1096) and
sometimes characterized by apathy and lack of drive or initiative (Neary & Snowden, 1996). It
seems most reasonable that this alteration in social conduct occurs progressively in some
people with ALS, such that symptoms exist on a continuum that may be related or unrelated to
the physical disease course.
Thoughts
Cognitive inflexibility, or perseveration, may be among the cognitive deficits observed
in ALS. Perseveration, described as “repetitive, abstract, involuntary, and represent[ing] a
failure of neuronal processes” (Thayer & Lane, 2002, p. 686), is characterized by an inability
to adaptively adjust one’s thoughts. This cognitive inflexibility makes it difficult to change the
way one thinks and feels, which may interfere with one’s ability to cope with challenges or
achieve goals. Even more, perseveration is associated with rumination (Davis & NolenHoeksema, 2000). Ruminations are “perseverating self-focused thoughts” (Hertel, 1998, p.
166) that can interfere with a person’s ability to inhibit thoughts, generate alternative ways of
thinking about a situation, or switch the focus of one’s attention (Davis & Nolen-Hoeksema,
2000; Watkins & Brown, 2002). One study reported that nearly half of patients with ALS
endorsed ruminating as a coping strategy and that higher rumination scores were related to
higher depression (Hecht et al., 2002). Despite the negative outcomes of perseverative
thinking, patients perceive rumination as a helpful strategy (Earll, Johnston, & Mitchell, 1993).
This may describe a more general tendency of people with ALS to engage in these
perseverative thought processes, and may account for the lack of regulatory effort expended to
overcome this tendency.
9

Repetitive thought is not always harmful (Segerstrom, Stanton, Alden, & Shortridge,
2003), but several factors may make worry an unhelpful problem solving strategy for patients
with ALS. First, patients’ decision making may have little impact on their ultimate disease
trajectory. Second, patients’ prognosis is generally known to be poor, which may make certain
forms of worry more maladaptive (Wilson, Centerbar, Kermer, & Gilbert, 2005). Last, if
patients’ self-regulatory resources are taxed or depleted, they might not only be more prone to
perseverative thoughts, but have less strength to engage in alternative thought processes. This
highlights the importance of viewing perseverative cognitions along a continuum in relation to
self-regulatory resources, such that at a mild or moderate level, perseverative cognitions may
be less harmful (or even helpful), but at high levels (i.e., where inhibitory processes are
ineffective), the consequences may be greatest.
Physiological Self-Regulation in ALS
Metabolic and autonomic resources may be important components of the capacity for
executive control, and may be especially important for people with ALS. First, EF are
considered “metabolically expensive” in terms of the amount of glucose required to optimally
function (Gailliot, 2008, p. 245). Specifically, low levels of blood glucose and poor glucose
tolerance have been linked to impaired performance on tasks involving processes that rely on
executive function (i.e., Stroop Test; Benton, Owens, & Parker, 1994; Fairclough & Houston,
2004) as well as SR (e.g., attention, impulsivity, emotion regulation; see Gailliot &
Baumeister, 2008 for a review). Furthermore, optimal levels and transport of glucose are
linked to increased ability to exert self-control (Huisman, Gucht, Maes, Schroevers, Chatrou,
& Haak, 2009) and better performance on cognitive tasks (Gailliot, 2008; Gailliot &
Baumeister, 2008). Thus, glucose is a resource that appears to be important to a person’s
ability to self-regulate in various domains, including EF.
10

Given that glucose enables SR in multiple domains, glucose levels and tolerance may
be especially important for people with ALS, who may be especially prone to self-regulatory
deficits. Indeed, there is evidence of impaired glucose transport in the cerebral cortex in some
rat models of ALS (Guo, Kindy, Kruman, & Mattson, 2000). Research has also revealed a
link between mild frontal dysfunction and reduced glucose metabolism in the cortex and
subcortical structures of ALS patients (Ludolph et al., 1992). Low glucose levels and impaired
glucose transport in people with ALS may partially account for impairments in self-regulatory
and executive abilities, which are expensive in terms of glucose. Specifically, for people with
ALS who have low glucose levels and/or impaired glucose transport (e.g., poor glucose
tolerance), executive impairments may be most pronounced. On the other hand, adequate
levels of glucose and optimal transport may enable people with ALS to self-regulate more
successfully across domains.
Another potentially important physiological correlate of self-regulatory capacity is
heart rate variability (HRV), an autonomic measure of beat to beat variations in heart rate that
“reflects the ability to allocate and maintain attention, which are crucial to the control of
emotion and performance” (Demaree, Pu, Robinson, Schmeichel, & Everhart, 2006, p. 162).
HRV, like glucose, is associated with prefrontal activity and SR (e.g., inhibition, cognitive
flexibility, delayed response). Specifically, low resting HRV may correlate with decreased
prefrontal activation, impaired EF, disrupted emotion modulation (i.e., enhanced/prolonged
threat response), and perseverative thoughts (Brosschot, Thayer, & Gerin, 2006; Thayer,
2007). Low resting HRV also predicts less persistence on tasks requiring self-regulatory effort
(Segerstrom & Solberg Nes, 2007). Additionally, elevated heart rate (HR) and decreased HRV
were independently associated with stressful events and worry (particularly worry about future
events), when controlling for personality, mood, and demographic factors (Pieper, Brosschot,
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Van der Leeden, & Thayer, 2007). However, increased emotional display and impaired
regulation of negative affect (e.g., anxiety, depression, hostility) have also been related to
“reduced cardiac vagal control” (i.e., HRV) (Carney, Freedland, & Stein, 2000; Demaree &
Everhart, 2004; Demaree, Pu, Robinson, Schmeichel, & Everhart, 2004; Friedman & Thayer,
1998a, 1998b).
There is converging evidence of impaired autonomic functions in ALS. In fact, some
suggest that “deterioration of sympathetic function is part of the disease process” (Oey, Vos,
Wieneke, Wokke, Blakestijn, & Karemaker, 2002, p. 403). ALS patients have “blunted vagal
control” (i.e., decreased HRV; Pisano, Miscio, Mazzuero, Lanfranchi, Colombo, & Pinell,
1995). Interestingly, this sympathovagal imbalance is not correlated with disease severity.
Not only may it be difficult to predict which people with ALS will suffer these cardiovascular
deficits, those patients with more salient or obvious motor impairments may sometimes be
more equipped to persist in the face of self-regulatory challenges than seemingly “intact”
patients, further highlighting the importance of examining the full range of deficits in ALS,
from sub-threshold to severe.
It is possible that the metabolic demands and autonomic responses involved in exerting
executive control and enabling SR are related. In fact, Brook and Julius (2000) propose that
autonomic imbalance is related to a range of cardiovascular abnormalities (including
metabolic). Decreased HRV has been linked to conditions involving impaired glucose
metabolism (e.g., diabetes; Schroeder et al., 2005; Ziegler, Dannehl, Volksw, Muhlen, Spuler,
& Gries, 1992). Taken together, these data imply that SR and EF are overlapping and related
constructs that rely on a similar energy resource (e.g., glucose) and that have at least one
common autonomic marker (e.g., HRV). These cardiovascular and metabolic factors
associated with SR may be particularly important for people with ALS. It could be true that
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the relationships between physiological factors (e.g., HRV, glucose) and SR are interactive.
Self-regulatory fatigue may tax metabolic energy resources, making them less available for
subsequent efforts at executive control, thereby resulting in the range of deficits noted in some
individuals with ALS. On the other hand, people with ALS may have impaired metabolic and
cardiovascular functions that limit the success of their attempts to self-regulate, thereby
resulting in the range of self-regulatory deficits in ALS.
Self-Regulatory Deficits and Well-being
Deficits across psychological and physical domains may not only share a common
mechanism (i.e., SR), but may also be interactive. For example, cognitive deficits (e.g., EF and
social cognition) can lead to altered interpersonal and socio-emotional functioning
(Zimmerman, Eslinger, Simmons, & Barrett, 2007). Refined assessment of self-regulatory
deficits across multiple domains may improve the prognosis of patients with ALS- not
pertaining to their physical health, but to their well being or quality of life (QOL).
Specifically, well being in a variety of domains (e.g., social, psychological, physical,
existential) is important to overall QOL, while disease progression or loss of physical function
appear to be less important to QOL (Averill, Kasarskis, & Segerstrom, 2007; Roach, Averill,
Segerstrom, & Kasarskis, 2009). In fact, when asked about the determinants of their own
QOL, people with ALS refer to the importance of “psychological and existential issues, and
support factors” rather than physical function (Simmons et al., 2000, p. 391). In one group of
people with ALS, decreased social support was the best predictor of psychological wellbeing
and self-esteem (Goldstein, Atkins, Landau, Brown, & Leigh, 2006). Evidence that higher
QOL results in longer survival (Johnston, Earll, Giles, McClenahan, Stevens, & Morrison,
1999; McDonald, Widenfeld, Hillel, Carpenter, & Walte, 1994) suggests that QOL is a
“critically important endpoint in ALS” (Hardiman, Hickey, & O’Donerty, 2004, p. 233) and
13

that it should be a major focus of clinical care and interventions (e.g., Chio et al., 2004, 2005;
Mitsumoto & DelBene, 2000).
Reduced ability to self-regulate could result from decreased baseline capacity or from
depleted executive resources due to the progressive and demanding disease course of ALS.
Regardless of the cause, an inability to adaptively adjust and pursue one’s goals (explicit or
implicit) ultimately influences the well being of people with ALS. Thus, examining SR in
ALS may enhance clinical interventions that tend to more narrowly focus on patients’ most
extreme (often motor) deficits.
Attending to the needs and well being of those providing the care for people with ALS
is equally crucial, given that caregiver mental status influences patients’ physical,
psychological and existential wellbeing (Rabkin, Wagner, & Del Bene, 2000). Some even
suggest that interventions to improve patients’ QOL should largely focus on caregivers, who
support patients and relieve their distress, and that health care providers should focus on
improving the coping skills of caregivers (Chio et al., 2004). Despite evidence that caregiver
well being is important to patient well being, caregiving appears to take quite a toll on the
QOL of these individuals. Caregivers in one longitudinal study exhibited a significant
increase of burden and depression over a 9-month period (Gauthier et al., 2007). Thus,
caregivers may be more psychologically vulnerable to patients’ disease-related physical
deterioration than patients themselves. Given that ALS is a multi-system disorder as described
above, factors other than physical disease progression may also be important to caregiver
QOL. Specifically, “patient’s cognitive functioning is an important factor in determining the
level of burden” of caregivers (Chio et al., 2005, p. 781). Thus, examining the range of selfregulatory deficits in ALS has implications for both patients and for those caring for them.
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The Current Study
The aims of this study were to test the following hypotheses in patients and caregivers:
1. There will be between-patient variability in EF and self-regulatory capacity.
Specifically, examining the distribution of executive and self-regulatory impairments (with
regard to emotions, thought processes, and social interactions) in patients will reveal
continuous distributions of scores on measures of SR and EF, supporting the idea that deficits
exist on a spectrum, rather than being discrete disease entities or classes, such as FTD.
2. Patients’ and caregivers’ ratings of SR will be positively correlated (Adelman,
Albert, Rabkin, Del Bene, Tider, & O’Sullivan, 2004) so that in general, as patients perceive
more problems, caregivers also perceive more problems. However, we expect mean-level
differences (patients will rate their problems as less severe than caregivers rate their problems)
as well as a non-linear relationship between patient and caregiver ratings of SR (as deficits
increase, patient and caregiver reports will diverge, possibly because patients aren’t able to
realistically evaluate their condition; Lezak, 1995) . If patient and caregiver reports are
moderately and linearly related, they will be combined into composite scores for SR and EF to
test subsequent hypotheses.
3. The third aim of this study is to establish the construct validity of EF and SR by
examining relationships among reports of SR in various domains (e.g., global regulation,
social regulation, emotional regulation, regulation of thought processes) and executive
functions in “hot” and “cool” domains. Moderate correlations (r ≥ .30) between different
measures of EF/SR and weaker relationships (r ≤ .10) with divergent measures would support
the use of composite EF/SR indices.
4. EF will contribute to self-regulatory capacity, even when controlling for potentially
confounding variables (e.g., intelligence, ventilation status, etc.).
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5. SR and EF will correlate with physiological measures of HRV and A1c.
Specifically, HRV will be lowest and A1c will be highest in those patients with more selfregulatory and executive deficits.
6. Patients’ self-regulatory capacity, executive functioning, and physiological factors
(i.e., baseline HRV and A1c) will contribute to QOL. Specifically, more self-regulatory and
executive impairment, lower baseline HRV, and higher A1c are expected to be associated with
poorer QOL. This may be especially true for caregivers.

Copyright © Abbey R. Roach, 2010
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Chapter Two
Method
Participants
Thirty-seven patients with motor neuron disease (31 ALS, 6 PLS) and their primary
caregivers were enrolled in the study. This sample provided adequate power (.90) to detect a
large effect (r = .50) of SR on EF. Demographic characteristics of the sample are provided in
Table 1. The sample was representative of the population of individuals diagnosed with motor
neuron disease with regard to gender and age (NINDS, 2003).
Thirty-seven caregivers were recruited to participate in this study. However,
demographic data were only available for 36 caregivers as 1 caregiver did not complete the
questionnaires. In general, men were more likely to be cared for by an opposite-gendered
caregiver and females were more likely to have a same-sex caregiver.
Procedure
Participants were recruited for the study though ALS clinics at the University of
Kentucky and Cardinal Hill Rehabilitation Hospital in Lexington, Kentucky. A letter was
mailed to all ALS clinic patients informing them about the study. Patients were encouraged to
respond (via an enclosed response card or via their physician during their clinic visit) if they
were interested in participating. A research assistant followed up with each patient either in
person or by phone to determine eligibility.
To be eligible for participation, the following criteria were met: diagnosis of ALS
(according to the El Escorial Criteria; World Federation of Neurology Research Group on
Motor Neuron Diseases, 1998) or PLS (Pringle, Hudson, Munoz, Kiernan, Brown, & Ebers,
1992), diagnosis greater than 6 months prior to participation, age between 30 and 90 years, no
diagnosis of Type 1 Diabetes, fluency in English, and having a caregiver willing to participate.
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Sixty-four patients expressed interest in this study. Fourteen individuals initially expressed
interest but declined to participate after hearing more about the study, 6 individuals cancelled
their appointments and were not able to reschedule, 2 individuals were diagnosed within the
past 6 months, 2 individuals were hospitalized with pneumonia prior to participating, 1
individual was diagnosed with Type 1 Diabetes, and 2 individuals died before participating in
the study. Thus, 37 patients provided informed consent to participate in this study.
Most patients were tested at Cardinal Hill Rehabilitation hospital (N=30). However, 7
patients were tested in their home because they were unable to travel to the testing site (e.g.,
due to mobility problems, lack of/cost of transportation, scheduling conflicts). Upon arriving
to the appointment, informed consent was reviewed with participants. Caregivers were
provided a packet of questionnaires to complete in a separate room. Physiological equipment
was attached to the patient, and the patient was instructed to sit and relax for 5 minutes to
obtain baseline physiological measurements. Upon completion of the 5 minute baseline
period, participants completed 2 computerized neuropsychological tests, the physiological
leads were removed, and 2 more neuropsychological tests (i.e., booklets) were administered.
Questionnaires (assembled in counter-balanced order) were then verbally administered to
patients by the principal investigator. Patients responded to each item using a visual scale card
provided. Upon completing these questionnaires, a finger prick was administered to obtain a
blood sample for measurement of A1c. Patients were offered breaks as needed throughout the
testing. The range of time required to complete the protocol was between 2 and 3 ½ hours
(Mean= 2.29 hours, SD= .34 hours). Participants were mailed $50 for participating in the
study.
Measures
Descriptive Measures
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Demographics. Demographic information (e.g., age, gender, ethnicity) was obtained
from patients and caregivers (see Table 1). Additionally, patients provided disease-related
information (e.g., dates of diagnosis and symptom onset, onset site).
Self-Regulation Measures
Revised Dyadic Adjustment Scale-cohesion scale (RDAS; Busby, Crane, Larson, &
Christensen, 1995). This is a 16-item self-report measure of relationship quality developed for
married or similar, cohabiting dyads. The revised version of the scale contains 3 subscales
(consensus, satisfaction, and cohesion) in addition to the total score. The 4-item cohesion
subscale (α=.80) was used in the current study to focus on patients’ social SR with the
individual providing their care. This subscale is composed of items that are not specific to
marital dyads (e.g., “how often do you and your [caregiver] work on a project together?”).
Lower scores indicate better relationship cohesion. The internal consistency of this scale in the
current sample was .81 for patients and .75 for caregivers.
Brief Fear of Negative Evaluation scale (BFNE; Leary, 1983). This self-report measure
of social anxiety (e.g., apprehension about being negatively evaluated, avoiding being
evaluated, and expecting the receipt of negative evaluation) consists of 12 items scored on 5point Likert-type scales. The scale was selected due to evidence that self-regulatory capacity
determines whether an individual is successful at overcoming social anxiety, which is shared,
to a certain extent, by all individuals (Baumeister et al., 2006). Lower scores on this scale are
more adaptive (i.e., indicative of less social anxiety). The internal consistency of this scale in
the current sample was .94 for patients and .96 for caregivers’ reports of patients.
Center for Neurologic Study- Lability Scale (CNS-LS; Moore, Gresham, Bromberg,
Kasarskis, & Smith, 1997). This is a 7-item self-report measure of affective lability in patients
with ALS. The scale consists of 2 subscales, labile laughing (4 items) and labile tearfulness (3
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items), both of which have acceptable internal consistency (.91 and .89, respectively).
Participants respond on a 5-point Likert scale, with higher scores indicative of more emotional
lability or dysregulation. The internal consistency of this scale in the current sample was .86
for patients and .78 for caregivers’ reports of patients.
Rumination Scale (RS; Martin, Tesser, & McIntosh, 1993). This was originally a 10item self-report measure of conscious, repetitive, persistent, aversive thought that is best
described by a two-factor solution (Segerstrom et al., 2003). The 4-item lack of control over
thoughts/ distractibility scale was used as a measure of ability to regulate one’s thought
processes in the current study. However, the internal consistency of this 4-item scale was poor
for both patients and caregivers in the current sample. The deletion of 1 item (i.e., “If I don’t
want to think about something, I am able to just stop thinking about it.”) from the scale
improved the internal consistency of patients and did not significantly affect that of caregivers,
resulting of alphas of .53 and .62, respectively. Lower scores on this scale represent better
ability to regulate one’s thought processes.
Behavioral Rating Inventory of Executive Functions (BRIEF; Roth, Isquith,
& Gioia, 1996). This is a 75-item measure of executive regulation of behavior with self- and
informant-report forms. This inventory consists of nine non-overlapping empirically derived
clinical scales that measure various aspects of executive functioning as applied to daily life
(Inhibit, Self-Monitor, Plan/Organize, Shift, Initiate, Task Monitor, Emotional Control,
Working Memory, Organization of Materials), that form two broader indexes of behavioral
regulation and meta-cognition. Both the scales and indexes have adequate internal
consistency, ranging from .73-.90 for clinical scales and .93-.96 for indexes on the self-report
form and .80-.93 for clinical scales and .95-.98 for indexes on the informant-report form. This
scale is appropriate to measure a variety of forms of SR, both from the patients’ and
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caregivers’ perspectives. In the current study, several items were deleted to prevent overlap
with disease symptoms. Specifically, items that were believed to be overlapping with the
physiological disease process involved in ALS or PLS (e.g., “taps fingers or bounces legs”,
“has trouble sitting still”, “lies around the house a lot”) were not included in the total score.
The total score was used in the current study as a self-reported measure of global regulation
with higher scores indicating worse global regulation.
Neuropsychological Measures
Iowa Gambling Task (IGT; Bechara et al., 1994). This computer-administered task
assesses “real-life” decision making ability in an “ecologically valid” paradigm in accordance
with Damasio’s (1995) somatic marker hypothesis. Participants are instructed to choose one
of four decks (A, B, C, D; 60 cards each) until 100 selections have been made. After each
selection, participants receive a reward and/or penalty in play money. The decks have predetermined rewards and penalties (e.g., Decks A and B have a high rewards and penalties,
decks C and D have low rewards and penalties). Additionally, decks A and C have more
frequent penalties and decks B and D less frequent penalties. A greater selection of cards from
decks A and B (disadvantaged decks) results in a net loss and a greater selection of cards from
decks C and D (advantage decks) results in a net gain. The performance measure used in this
study was the number of cards picked from advantaged decks minus the number of cards
picked from disadvantaged decks. After reversing the direction of this scale, lower scores
indicate better “hot” executive function.
Wisconsin Card Sorting Test (WCST; Berg & Grant, 1948). This task requires
participants to sort response cards (i.e., according to color, shape, and number) according to
feedback (i.e., right or wrong) until they have matched six categories or sorted all 128 cards.
The sorting rules change after 10 consecutive correct card sorts, requiring participants to
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demonstrate cognitive flexibility to shift sets. The performance measure used in the current
study was the number of perseverative errors, which represents cognitive inflexibility or
failure to shift sets in response to changing demands (Ridderinkhof, Span, van der Molen,
2002). Although there is controversy surrounding the validity of this test as a measure of EF,
it is the most frequently used measure of EF and is viewed as a “sensitive but not specific
marker of frontal lobe damage” (Alvarez & Emory, 2006, p. 19). Lower scores indicate better
“cool” executive function.
Benton’s Judgment of Line Orientation-Form H (BJLO; Benton, Varney, & Hamsher,
1978). This is a standardized measure of “pure” visuospatial processing used to provide
discriminant validity for EF. The spiral-bound booklet contains 35 stimuli (i.e., 5 practice
items, 30 test items) with 11 response choices (i.e., lines). Validity and reliability of this task
are high (.84; Riccio & Hynd, 1992). Higher scores indicate better visuo-spatial skills.
Autonomic Functioning: Heart Rate Variability (HRV)
HRV is a measure of parasympathetic control over the heart that is an index of selfregulatory capacity (Segerstrom & Solberg Nes, 2007). Parasympathetic activity leads to
more variable intervals between heart beats, and therefore higher HRV. The Ambulatory
Monitoring System (Vrije Universiteit, Amsterdam, The Netherlands) was used during a 5minute baseline period (prior to the administration of any other measures) to produce an
electrocardiogram (and provide indexes of HR and HRV), with leads attached to the forearms
and leg in a Lead II configuration. The electrocardiogram was sampled at 1,000 samples/s.
Beats per min and mean squared successive differences in the inter-beat interval (HRV) were
calculated on-line and stored in 30-second epochs. HRV was calculated as the root mean
squared successive differences in the inter-beat interval (Task Force of the European Society
of Cardiology and the North American Society of Pacing and Electrophysiology, 1996) and
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was examined in relation to self-regulatory abilities across domains as assessed by self-report
measures and neuropsychological testing.
Metabolic Functioning: Glycosylated Hemoglobin
Hemoglobin A1c (A1c) was measured to assess the overall effectiveness of blood
glucose control over the past 2-3 months. Given that the long-term self-regulatory capacity
and its practical impact on functioning were of interest in the current study, A1c was an
appropriate glucose test as it reflects the course of glucose control over a more extended time
period than other glucose measures and therefore, it is less sensitive to short-term fluctuations.
The optimal level of A1c is debated, but it is generally suggested the estimate not exceed 6%
for normal individuals and 7% for diabetic individuals (American Diabetes Association, 2007).
Thus, lower values generally reflect “better” functioning. This measure was taken on site
using the A1c NOW+ monitor (Metrika), which involved obtaining a drop of blood via finger
stick delivered by a lancet device.
Well-being Measures
McGill Quality of Life Questionnaire (MQOL). This is a 16-item self-report scale
measuring subjective well being in terminally ill populations (Cohen, Mount, Strobel, & Bui,
1995). Four of the five sub-scales relating to physical well being, psychological well being,
existential well being, and social support comprise a total score (α=.80), which was used in the
current study (i.e., the 3-item physical symptoms subscale will be excluded). Items are
measured on a Likert-scale ranging from 0 to 10, with lower scores indicating poor quality of
life and higher scores indicating good quality of life. The internal consistency of patients on
this scale was .90.
Quality of Life in Life Threatening Illness Family Carer Version (QOLLTI-F; Cohen,
Leis, Kuhl, Charbonneau, Ritvo, & Ashbury, 2006). This is a 16-item measure of caregiver
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well being that takes the perception of the condition of the patient into account. This scale,
derived based on what caregivers state is most important to their well being, is composed of 7
domains (i.e., carer’s own state, environment, carer’s outlook, quality of care, relationships,
patient condition, financial) that have acceptable internal consistency (∝=.48 (environment).81 (carer’s own state)) as well as test-retest reliability (.50-.79). The internal consistency of
the total score (i.e., the average of the 7 domain scores) in this caregiver sample was .90.
Higher scores indicate better QOL.
Revised Dyadic Adjustment Scale-satisfaction item (RDAS; Busby et al., 1995).
Patients and caregivers rated their current satisfaction in their relationship on a 0-100 scale (0=
completely unhappy, 100=completely happy).
Potential Confounds
Functional Status. The ALS Functional Rating Scale (ALS-FRS) is a 12-item selfreport scale used to assess activities of daily living for people with ALS (e.g., speech,
handwriting, dressing/hygiene, walking; ACTS, 1996). The scale consists of 4 scales relating
to coordinated upper limb motions, bulbar function, breathing, and gross, less finely controlled
activities. The total score averages item responses (α=.90). Item test-retest reliability has
been demonstrated (≥.88). Consensus ratings between patients and caregivers assess the
difficulty of specific tasks. Lower scores on a 1 to 4 scale indicate more functional difficulty.
The internal consistency of this scale in the current study was .83.
Intelligence. Standard Progressive Matrices (SPM; Raven, 1948) is a multiple-choice,
non-verbal abstract reasoning test that is one component of Spearman’s g (general intelligence;
Strauss, Sherman, & Spreen, 2006). This 60-item test involves patients selecting one missing
piece from 6 or 8 alternative missing pieces to complete a stimulus figure. The test has high
internal consistency (> .70; Burke, 1985) and test-retest reliability (>.80; Raven, 2000).
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Data Analysis
Alpha was set at .05, two-tailed, for all inferential tests. Continuous predictors were
centered prior to regression analyses.
Missing data were imputed from the available data using SPSS Missing Value
Analysis. This procedure imputes missing values through expectation maximization (EM)
algorithms. Reasons for missing data included: patient fatigue, time constraints, inability to
reschedule, and caregiver non-response. The following is the breakdown of missing variables
that required imputation. For patients, data were imputed for the BRIEF-A, JLO, RS, CNSLS,
FNE, and MQOL for 1 individual each. For caregivers, 2 participants failed to complete the
BRIEF-A Informant Report and 1 participant failed to complete all questionnaires including
demographics and SR measures. However, these data are believed to be missing at random
(MAR), which is a typical and relatively safe assumption, and thus accommodated by our
analyses (Schafer & Graham, 2002).
Prior to primary analyses, preliminary analyses were conducted. First, despite having
small sample sizes, t-tests and chi-square tests examined demographic differences between
patients with ALS (N=31) and PLS (N=6). ALS and PLS patients significantly differed with
regard to gender (X2 (1, 37) = 4.03, p < .05) and marital status (X2 (1) = 12.15, p < .01), such
that ALS patients were more likely to be male and married than PLS patients. However, t-tests
revealed a lack of significant differences between these groups on nearly all substantive
variables. Only 1 of the 18 comparisons was significant at p < .05. When comparing A1c
values of patients without diabetes to those with type 2 diabetes (N=3), there were no
significant differences, suggesting that diabetes status should not be statistically controlled in
analyses.
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The test of Hypothesis 1 primarily involved exploratory data analyses to examine the
distributions of each dependent variable. First, univariate analyses (i.e., descriptive statistics
and scatterplot/boxplot examination) revealed outliers in the data, the degree and direction of
asymmetry of the distribution (skewness), and the peakedness of the distribution (kurtosis) of
each variable. Given that skewness statistics can be misleading, especially in small samples, a
conservative approach was taken in evaluating when to remove outliers or transform data. In
this study, variables with skewness statistics that were ≥ 2 standard errors were examined for
removal of outlier(s) and considered for transformation. However, given that there is no
universally applicable rule of thumb in interpreting these estimates, histograms and residual
plots were closely examined before data transformation. When appropriate, data were log
transformed to achieve a normal distribution. This examination of the distribution of values
not only identifies whether deficits exist on a continuum or not, but it also informs whether
there are subsequent constraints on r and whether the assumptions of regression analyses are
violated with regard to linearity and normality of the dependent variables.
The test of Hypothesis 2, regarding patient-caregiver agreement, involved 4 primary
components. First, paired samples T-tests were conducted to examine mean-level differences
between patients and caregivers. Next, a correlation matrix was calculated to determine if
there is a positive (e.g., moderate) correlation between raters. Next, scatterplots were
examined to detect curvilinearity. Finally, non-linear relationships were then entered into a
curve estimation regression (simultaneously) to examine the nature of the relationship.
Post-hoc analyses were conducted to examine discrepant patient-caregiver ratings of
SR. First, this involved the creation of a discrepancy score (patient rating-caregiver rating) for
each scale on which there was disagreement between patient and caregiver reports. Next,
these discrepancy scores were regressed onto the neuropsychological measures of EF to
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determine whether differences in executive functioning contributed to patient-caregiver
discrepancies. The first step included the main effects (i.e., “cool” EF, “hot” EF) and the
second step included the main effects and their interaction (“cool” EF* “hot” EF). The
interactions were probed to examine the nature of the differences between the main effects for
patients and caregivers. Last, repeated-measures regressions examined within-subject effects
of person (i.e., patient v. caregiver) on the interaction between “cool” EF and “hot” EF
performance in predicting SR. The “person” factor had 2 levels (i.e., patient report and
caregiver report) and the 3 covariates were performance on the WCST, IGT, and the
interaction (i.e., WCST*IGT).
A similar procedure was used to test Hypothesis 3, which involved computation of a
correlation matrix to examine the relationships among the various measures of SR and EF.
The use of composite indices of EF (e.g., “cool” EF, “hot” EF) and SR (e.g., emotional
lability, rumination, social anxiety, dyadic cohesion, and global regulation) would be justified
by moderate to high correlations (r ≥ .30) with related constructs and weaker relationships (r ≤
.10) with divergent measures. A lack of support for composite constructs would result in each
scale being examined separately in subsequent analyses.
Zero-order correlations were examined to test Hypothesis 4, that superior “hot” and
“cold” EF would be associated with better self-regulatory ability across domains. The need to
statistically control for some variables (e.g., intelligence, time of assessment, respiratory
functioning, and functional status) was examined. In general, examination of partial
correlations revealed that the relationship between caregiver ratings of rumination and
patients’ “cool” EF may be attributed to the overlap between IQ and EF.
The test of Hypothesis 5 was similarly conducted by examining zero-order correlations
among facets of SR and measures of physiological functioning. Again, the need to statistically
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control for some variables (e.g., intelligence, time of assessment, respiratory functioning, and
functional status) was explored, but was largely unnecessary given the lack of significant
relationships.
Hypothesis 6 involved the computation of a correlation matrix to determine if better
self-regulatory abilities and physiological functioning would predict better QOL and more
relationship satisfaction for patients and caregivers. Again, given the lack of relationship
between potential confounders (e.g., age, gender, time of assessment, ventilation status, and
functional status) and the variables of interest (i.e., QOL, relationship satisfaction), no
statistical controls were included in analyses and zero-order correlations were sufficient to
examine these relationships. Additional hierarchical regressions were employed to examine
the unique contribution of caregiver ratings to patients’ ratings of QOL, above and beyond
patient ratings, and vice versa. Thus, patient QOL was regressed onto patient ratings of SR in
step 1 and caregiver ratings of SR in step 2. Similarly, in a second regression, caregiver QOL
ratings were regressed onto caregiver ratings of patient SR in step 1 and patient ratings in step
2.
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Table 2.1
Descriptive Characteristics of Sample
Variable

Patients

Caregivers

Age

59.97 (11.57)

58.33 (13.31)

Male

54.1 % (N=20)

27 % (N=10)

Female

45.9% (N=17)

70 % (N=26)

Caucasian

97 % (N=36)

95 % (N=35)

Latino

3 % (N=1)

3 % (N=1)

Gender

Ethnicity

Marital Status
Married

84 % (N= 31)

Divorced

8 % (N= 3)

Widowed

5% (N= 2)

Single

3% (N=1)

Education (years)

13.81 (3.73)

Household Income (annual)

$53,151 ($32,477)

Disease Type:
ALS

84 % (N=31)

PLS

16 % (N=6)

Onset Type:
Limb

78 % (N=29)

Bulbar

22 % (N=8)

Months Since Diagnosis

36.02 (34.52)

Months Since Onset

57.65 (42.66)
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Functional Status (ALS-FRS)

30.66 (9.19)

Response Mode:
Verbal

81 % (N=30)

Non-Verbal

19 % (N=7)

Note.75% of the patients’ caregivers were a spouse living in the same household
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Chapter Three
Results
Distribution of SR and EF in Patients
Descriptive statistics revealed that most continuous variables were normally
distributed. Examination of skewness statistics, scatterplots, and boxplots revealed no
problematic outliers or significant skewness for most variables (see Table 2). However, there
were 2 variables for which the skewness statistic was ≥ 2 standard errors, which warranted
consideration for transformation. Upon examining the distribution of the WCST variable
(skewness = 1.04, SE=.39), the slight positive skew looked acceptable on a boxplot. There
were no significant outliers and data were continuously distributed. Thus, this variable was not
transformed. On the other hand, the HRV data (i.e., MSSD), which was also positively
skewed (skewness = 2.94, SE=.39), evidenced several outliers. These outliers were closely
examined and considered for removal from the data. However, only 2 data points (426.60,
592.67) were removed due to them falling outside the typical range of MSSD values (i.e., <
290) as established in a large undergraduate sample (N=166) using the same equipment and
software. The other outliers (274.22, 238.08, 182.46) were not removed because they were
within the range of reasonable MSSD values. The removal of these 2 outliers however, did
not entirely correct the skewness of this variable. Thus, the data was also log transformed (i.e.,
log10) to achieve a normal distribution (skewness =.34, SE=.40).
Thus, normal and continuous distributions suggest that self-regulatory and executive
impairments in ALS do exist on a spectrum, rather than as discrete disease entities, as
predicted in Hypothesis 1.
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Patient-Caregiver Agreement
The first part of Hypothesis 2 proposed positive correlations between patient and
caregiver ratings of patient SR function. The correlations in Table 3 revealed that patientcaregiver agreement in rating SR and EF ranged from weak to strong, but was generally
positive (range: -.14-.58; mean r = .10). Specifically, there was strong agreement with regard
to emotional lability (r = .58; p < .01), such that as caregivers perceived more lability, patients
also perceived more lability. Likewise, there was a moderate to strong positive relationship
between patients’ and caregivers’ report of patients’ social anxiety (i.e., BFNE; r = .43, p <
.01). Patient and caregiver reports of patients’ global regulation were also moderately
correlated (r = .31, ns). However, there was less patient-caregiver agreement on cohesion (r =
.19, ns), and there was virtually no relationship between patient and caregiver ratings of
rumination, that is, patients’ ability to regulate thought processes (r = .15, ns), indicating that
patient-caregiver reports of relationship cohesion and patient ability to regulate thought
processes were more discrepant. Therefore, this part of Hypothesis 2 was partially supported:
Moderate to high patient-caregiver agreement characterized emotional and more global
measures of patient SR, but there was little agreement on cognitive measures of SR and,
surprisingly, on cohesion in the patient-caregiver relationship.
The second part of Hypothesis 2 proposed mean differences between patients and
caregivers such that patients would perceive themselves to have better SR function than would
caregivers. Table 3 includes means and standard deviations for the SR measures for patients
and caregivers. Paired samples T-tests revealed no significant mean level differences between
patient and caregiver ratings of emotional lability (t(1, 35) = 1.74, ns) or social anxiety (t(1,
35) = 1.26, ns). However, there was a significant difference between patient and caregiver
reports of patients’ global regulation (t(1, 35) = 2.15, p < .05), such that caregivers perceived
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patients to be functioning better than patients perceived themselves to be functioning. There
was also a significant difference between patient and caregiver reports of relationship cohesion
(t(1, 35) = 2.27; p < .05), where caregivers perceived more cohesion than patients. Therefore,
these results are opposite the predicted pattern in Hypothesis 2, which suggested that patients
would perceive themselves to be functioning better than caregivers perceived them to be
functioning.
The final part of Hypothesis 2 proposed that disagreements between patient and
caregiver reports could arise from nonlinear relationships or patients’ cognitive function.
These possibilities were explored with regard to cohesion and rumination, where there was
disagreement. Curve estimation regression revealed a non-linear, quadratic relationship
between patient and caregiver reports of dyadic cohesion (β=.42, F(2,36)= 4.27, p < .05, ΔR2=
.16). Although there was a tendency for patients to rate cohesion as low compared to
caregivers, the highest agreement occurred at lower scores (i.e., when cohesion was higher)
and to a lesser degree, at agreement at higher scores (i.e., when cohesion was lower). While
caregivers perceived high cohesion and patients perceived low cohesion in some instances, the
opposite pattern in which patients perceived high cohesion and caregivers perceived low
cohesion, did not emerge (see Figure 1). Post-hoc analyses of patient-caregiver discrepancies
on rumination and cohesion attempted to examine the contribution of EF to these
discrepancies. Thus, the discrepancy score for each scale was regressed onto EF measures
(WCST, IGT) in separate analyses. A lack of significant effects (rumination discrepancy
→”cool” EF: t(1,35)= 1.19, ns; rumination discrepancy →”hot” EF: t(1,35)= .02, ns; cohesion
discrepancy →”cool” EF: t(1,35)= 1.82, ns; cohesion discrepancy →”hot” EF: t(1,35)= -.17,
ns) indicated that these discrepant views of patient’s self-regulatory capacity could not be
explained by differences in executive capacity.
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However, it was suspected that the interaction of the EF measures (WCST*IGT) may
account for more variance in SR than each measure alone. Also, to explore whether the effects
of the interaction on SR differed depending on the rater (e.g., patient v. caregiver), repeated
measures regressions examined the within-subject effect of person on the interaction between
“hot” and “cool” EF. There was a tendency (p < .10) for the interaction to predict dyadic
cohesion differently for patients and caregivers. For patients, good “hot” EF was associated
with more cohesion only if there was also good “cool” EF. Good “hot” EF was associated
with less cohesion if there was poor “cool” EF for patients. Poor “hot” EF was generally
related to less cohesion for patients, and this was most true if patients had good “cool” EF (see
Figure 2). The opposite pattern emerged for caregivers, such that poor “hot” EF was generally
associated with more cohesion, and this was most true if patients had good “cool” EF. On the
other hand, good “hot” EF was associated with more cohesion if there was poor “cool” EF (see
Figure 3). Finally, when patients had good “cool” EF, caregivers rated patients as less likely
to ruminate, and this was especially true when patients also had good “hot” EF.
Thus, results partially align with Hypothesis 2, in that there was a non-linear
relationship between patient and caregiver ratings of dyadic cohesion. However, patients and
caregivers agreed most when both perceived more cohesion. This pattern was not explained by
“hot” or “cool” EF.
Are Self-Regulation Measures Unitary?
The first part of hypothesis 3 aimed to establish construct validity for SR. A
correlation matrix revealed that the relationships among various domains of SR varied for both
patients (see Table 4) and caregivers (see Table 5). Patients’ reports of SR capacities in
different domains were generally in the weak to moderate range (range: -.17-.60; mean r =
.20), and were less consistent than caregivers’ (range: -.13-.51; mean r = .30). There was a
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strong, positive correlation between patients’ reported social anxiety and rumination, such that
as patients perceived less social anxiety, they perceived less rumination (r = .60, p < .01).
Patients’ global regulation correlated most strongly and consistently with other measures of
self-regulation. Thus, as patients perceived themselves as having more global regulatory
ability, they perceived themselves as being less emotional labile, less ruminative, and less
socially anxious. On the other hand, better global regulation was related to perceptions of less
dyadic cohesion.
In general, a similar pattern emerged for caregivers (see Table 5). However, the
relationships among caregiver reports of patients’ SR across domains were generally stronger.
Specifically, caregivers perceptions of emotional lability, social anxiety, and dyadic cohesion
converged, such that better functioning in one domain was associated with better functioning
in the other domains. Similarly caregiver ratings of patient tendency to ruminate was related
social anxiety in the expected direction, with more rumination associated with more social
anxiety. As was true for patients, caregiver rated global regulation was most strongly and
consistently correlated with other measures of SR. As caregivers rated better global
regulation, they also rated less emotional lability, less rumination, less social anxiety, and to a
lesser degree, more dyadic cohesion (r = .15, ns). This divergence among domains of selfregulation, which was particularly evident for patients, does not support Hypothesis 3 or the
use of composite indices of SR that combine measures of SR into a single index. In general,
caregivers perceived a more pervasive pattern of deficits (evidenced by higher correlations
across measures) compared with patients, who viewed their deficits to be less cohesive and
more idiosyncratic.
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Are Cognitive Measures Unitary?
The second part of Hypothesis 3 aimed to examine the construct validity of EF. A
correlation matrix (Table 6) revealed that although there was a small to moderate relationship
between measures of “hot” and “cold” EF as expected, there was sufficient evidence to
conceptualize these as distinct EF components. While there was a divergent relationship
among measures of EF and visuo-spatial skills, intelligence was consistently associated with
the other cognitive measures. Therefore, the subsequent correlations among “hot” EF, “cold”
EF, and SR measures statistically controlled for intelligence. Hypothesis 3 was supported in
that “hot” and “cool” EF were more strongly correlated to one another than to an unrelated
construct.
How much does EF contribute to SR?
Hypothesis 4 proposed that EF would contribute to SR. Given the lack of support for
composite SR and EF constructs, “hot” and “cool” components of EF were examined in
relation to individual domains of SR (i.e., thought regulation, social anxiety, emotion
regulation, global regulation), primarily using zero-order correlations. However, given the
significant relationship among intelligence and both EF and SR constructs, a separate set of
correlations controlled for intelligence (see Table 7). Specifically, higher intelligence was
related to better “hot EF” (r = -.34, p < .05), more social anxiety (patient rated; r = .35, p <
.05), less dyadic cohesion (caregiver rated; r = .47, p < .01), and less rumination (caregiver
rated; r = -.41, p < .01). There was no need to statistically control for other suspected
confounds (e., respiratory functioning, time of assessment, and functional status).
Correlations between EF performance and SR reports were generally in the small to
medium range. Better “cool” EF significantly correlated with less rumination by caregiver
report (but not by patient report). This relationship was no longer significant when
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intelligence was partialled out. Smaller, non-significant correlations suggested that better
“cool” EF also related to better relationship cohesion by patient report, but worse cohesion by
caregiver report. There were no significant correlations between “hot” EF and SR. Again,
smaller, non-significant correlations suggested that better “hot” EF was related to better
relationship cohesion by patient report and worse cohesion by caregiver report. This pattern of
results is largely reflected in Figures 2 and 3, which show the effects of EF on patient and
caregiver reports of cohesion.
In sum, the contribution of EF to SR depended on several factors, including the EF
component (i.e., “hot” v. “cool”), the individual rating patient self-regulatory capacity, and the
domain of SR. Consequently, Hypothesis 4 is partially supported.
Physiological Functioning: Does EF or SR matter?
Hypothesis 5 proposed that better “cool” and “hot” EF, and better ability to self
regulate across domains, would be associated with more optimal metabolic (i.e., lower A1c)
and autonomic functioning (i.e., higher HRV). First, though not an explicit hypothesis, better
physiological health was expected to converge across measures of metabolic and autonomic
functioning. However, this relationship between A1c and HRV did not hold (r = -.05; ns).
Thus, support for the hypothesized relationships between EF and SR were limited by the
divergence of these two physiological measures.
As shown in Table 8, correlations among autonomic functioning (i.e., HRV) and
measures of SR and EF were generally in the small to medium range. For patients, less
emotional lability was significantly related to higher (i.e., more optimal) HRV.2 On the other
hand, better “cool” EF was significantly related to lower HRV. Smaller, non-significant
2

A significant relationship between HRV and patient age (r = .45, p < .01), did not significantly change the
relationship between emotional lability and HRV or the relationship between WCST performance and HRV when
it was statistically controlled in step 1 of a hierarchical regression. Thus, to preserve power (i.e., more df), zeroorder correlations were preferred.
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correlations suggested that less rumination, less social anxiety, and more global regulation
were related to higher HRV and better autonomic functioning. While there were no significant
relationships between caregiver rated SR and patients’ HRV, correlations revealed a
relationship between less emotional lability, more relationship cohesion, less social anxiety,
better global regulation, and higher HRV. In sum, as expected in Hypothesis 5, better
autonomic functioning was related to better SR in several domains (albeit these relationships
were not always statistically significant). However, “hot” and “cool” EF did not relate to HRV
in the expected direction, as better EF was associated with lower (i.e., worse) HRV.
Correlations among measures of SR, EF, and metabolic functioning were generally
smaller in magnitude than those with autonomic functioning, and this was most true for
patients. Although largely non-significant, correlations were generally small to moderate in
size. There was convergence between patient and caregiver ratings of global self-regulation,
such that better perceptions of global self-regulation were significantly associated with better
regulated glucose (i.e., lower A1c)3. Smaller, non-significant correlations indicated that the
pattern of relationships was stable for both patients and caregivers, such that for both raters,
less emotional lability, less rumination, less social anxiety, better global regulation, and more
dyadic cohesion were associated with lower (i.e., better) A1c values. Again, Hypothesis 5 was
partially supported with regard to the relationships between metabolic functioning and global
self-regulation. However, on the whole, results did not converge across measures of
physiological functioning suggesting that different components of SR and EF may be more or
less important for optimal physical functioning, depending on the physiological parameter
examined.

3

A significant relationship between A1c and time of assessment (r = .38, p< .05), did not significantly change the
relationship between global regulation and A1c for patients or caregivers. Thus, to preserve power (i.e., more df),
zero-order correlations were preferred.
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Patient and Caregiver QOL: What really matters?
Hypothesis 6 proposed that better functioning across domains of SR, “hot” and “cold”
EF, and better physiological functioning would contribute to better QOL for both patients and
caregivers. A correlation matrix including patient and caregiver ratings of SR, EF, and QOL
informed the contribution of SR (as rated by both patients and caregivers) to QOL (as rated by
both patients and caregivers). Results are shown in Table 9. Although not an explicit
hypothesis, the relationship between patient and caregiver QOL and relationship satisfaction
were of interest. Correlations revealed that these relationships were weak (QOL: r = .12, ns;
relationship satisfaction: r = .21, ns), which is consistent with previous research.
First, patient perceptions of SR were moderately associated with patients’ QOL. When
patients perceived less rumination, more dyadic cohesion, and less social anxiety, they rated
significantly better QOL. Smaller, non-significant correlations revealed a similar pattern for
emotional lability and global regulation, such that better functioning was related to better
QOL. While better “cool” EF appeared to positively relate to QOL, better “hot” EF was
related to worse QOL for patients. With regard to physiological functioning, lower levels of
A1c (i.e., better metabolic functioning) and higher HRV (i.e., better autonomic functioning)
were related to better QOL as rated by patients, although these correlations did not reach
significance. In sum, Hypothesis 6 was generally supported with regard to patient QOL, as
better SR, better “cool” EF, and better physiological functioning were associated with better
QOL.
Not surprisingly, patient perceptions of SR were not as strongly or consistently related
to caregivers’ ratings of QOL. Correlations between patients’ ratings of SR and EF and
caregiver rated QOL were generally weak and non-significant. This idiosyncratic pattern of
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results indicates that patient reports of SR, as well as their EF and physiological functioning,
are less important to caregiver QOL, which does not support Hypothesis 6.
Given that patient ratings of SR were more closely related to patient rated QOL, a
similar pattern was expected to emerge for caregiver ratings of patients’ SR and caregiver
rated QOL, given shared rater variance. Although caregivers’ QOL was not significantly
influenced by their perceptions of patients’ self-regulatory functioning in any domain, as
reflected by weak to moderate, non-significant correlations, caregiver ratings of SR were
generally correlated with their QOL more strongly than patient ratings of SR, when comparing
domains (except dyadic cohesion). Caregiver perceptions of patient SR were less important to
patient rated QOL, as reflected in generally weak, non-significant correlations. In sum, ratings
of SR, EF, and physiological functions appeared to be most convergent when the rater was the
same (i.e., when patients’ SR ratings were correlated with patient QOL, when caregiver SR
ratings were correlated with caregiver QOL).
Given the lack of strong and significant correlations between ratings of SR and QOL,
even when rated by the same individual, a series of hierarchical regressions was conducted to
examine other factors that might contribute to QOL ratings, above and beyond an individual’s
perception of SR. Although patient perceptions clearly influenced their own QOL more than
their caregiver’s QOL, and vice versa, the contribution of the “other rater” to self-ratings
remained unclear. That is, the incremental contribution of others’ perceptions, above and
beyond self perceptions, to QOL were examined for both patients and caregivers. Caregivers’
ratings’ of patients’ SR abilities accounted for 2% of the variance in patients’ QOL, above and
beyond patients’ own perceptions. On the other hand, when predicting caregiver QOL,
patients’ perceptions of their self-regulatory abilities accounted for an additional 7% of the
variance in caregiver QOL, above and beyond caregivers’ own perceptions of patients’
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functioning. In sum, patients’ perceptions of their SR abilities appeared to contribute more to
caregiver QOL than caregivers’ perceptions contributed to patients’ QOL.
The last component of Hypothesis 6 involved relationship satisfaction, as rated by both
patients and caregivers. Specifically, better SR, EF, and physiological functioning were
expected to correlate with more satisfaction, as rated by both patients and caregivers. A
correlation matrix (see Table 4) revealed a similar pattern of generally weak to moderate
relationships, especially for patient ratings of SR, EF and physiological functions. Patient
ratings of SR significantly contributed to patient relationship satisfaction in a single domain,
dyadic cohesion (r = -.38, p < .05). The relationships among other patient ratings were
generally in the expected direction, but were weak to moderate, and non-significant. Patient
ratings similarly contributed little to caregiver ratings of relationship satisfaction. The pattern
of relationships among patients’ SR, EF, and physiological functions was again, more
idiosyncratic. While there was a significant correlation between patients’ “hot” EF and
caregiver relationship satisfaction, it was opposite the expected direction, with better “hot” EF
corresponding to worse relationship satisfaction for caregivers. While patient ratings of SR
were generally weakly and inconsistently related to relationship, caregiver ratings reflected a
different pattern.
In general, caregiver ratings of patient SR were moderately and consistently related to
relationship satisfaction, for both patients and caregivers. That is, when caregivers perceived
patients to have more SR, both patients and caregivers rated higher relationship satisfaction.
Although only one correlation reached significance (dyadic cohesion/caregiver relationship
satisfaction, r = -.59, p < .01), caregivers’ ratings of patient SR across domains converged,
supporting the idea that caregivers hold a more global view of deficits compared to patients.
This global view, whether pertaining to self-regulatory strength or deficit, appears to
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contribute to relationship quality for both patients and caregivers. In general, these results
partially supported Hypothesis 6, that better SR would correspond to better relationship
satisfaction. This was most true when caregivers rated patients SR.

Copyright © Abbey R. Roach, 2010
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Table 3.1
Distribution Statistics of Variables of Interest
Skewness Statistic (SE=.388)
Measure

Patient

Caregiver

WCST

1.038

-

IGT

-.364

-

JLO

-.322

-

SPM

-.534

-

A1c

-.707

-

MSSD

2.943a, .335b

-

BRIEF A

.388

.701

CNSLS

.927

.212

RS

-.645

-.173

BFNE

.528

.509

RDAS

.638

.377

ALS-FRS

-.128

-

QOL

-.857

-.329

Note. WCST = Wisconsin Card Sorting Test; IGT = Iowa Gambling Test; JLO = Judgment of
Line Orientation Test; SPM= Standard Progressive Matrices; A1c = glycosolated hemoglobin;
MSSD = heart rate variability; BRIEF-A = Behavior Rating of Executive Functions-Adult
version; CNSLS = Center for Neurologic Study- Lability Scale; RS = Rumination Scale;
BFNE = Brief Fear of Negative Evaluation Scale; RDAS = Revised Dyadic Adjustment Scale;
ALS-FRS= Amyotrophic Lateral Sclerosis Functional Rating Scale; QOL= Quality of Life
a

Skewness statistic prior to transformation; bSkewness statistic following transformation.
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Table 3.2
Inter-correlations Among Patient and Caregiver Reports of Patients’ Self-Regulatory Capacity
Caregiver Ratings

Patient Ratings
Global

Variable

M (SD)

Emotional Lability

Rumination

4.21 (5.45)
.581**

Lack of Cohesion

Social Anxiety

Dysregulation

-15.09 (4.36) 8.02 (4.23)

28.63 (11.81)

95.89 (17.94)

-.031

-.032

.152

.196

12.89 (4.47)

Rumination

-15.33 (4.10) -.136

.148

.001

-.139

.299

Lack of Cohesion

6.19 (3.41)

-.068

.192

.159

.045

Social Anxiety

25.97 (12.12) .090

.152

-.068

.425**

.050

Global Dysregulation 88.30 (18.62) .035

.074

-.257

.125

.312

47

Emotional Lability

.232

Note. Emotional Lability, Center for Neurologic Study- Lability Scale; Rumination, Rumination Scale; Lack of Cohesion, Revised
Dyadic Adjustment Scale; Social anxiety, Fear of Negative Evaluation Scale; Global Dysregulation, Behavior Rating of Executive
Functions-Adult version.
*p < .05; **p < .01.

Table 3.3
Inter-correlations Among Patients’ Ratings of Self-Regulation Across Domains
Variable
Emotional Lability
Rumination
Lack of Cohesion
Social Anxiety
48

Global Dysregulation

Emotional Lability
1

Rumination

Lack of Cohesion

Social Anxiety

Global Dysregulation

.100

.125

.167

.325*

1

-.047

.597**

.456**

1

.064

-.170

1

.224
1

Note. Emotional Lability, Center for Neurologic Study- Lability Scale; Rumination, Rumination Scale; Lack of Cohesion, Revised
Dyadic Adjustment Scale; Social anxiety, Fear of Negative Evaluation; Global Dysregulation, Behavior Rating of Executive
Functions-Adult version.
*p < .05; **p < .01.

Table 3.4
Inter-correlations Among Caregivers’ Ratings of Self-Regulation Across Domains
Variable

Emotional Lability

Rumination

Lack of Cohesion

Social Anxiety

Global Dysregulation

Emotional Lability

1

.180

.395*

.353*

.440**

1

-.130

.347*

.513**

1

.196

.146

1

.347*

Rumination
Lack of Cohesion
Social Anxiety
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Global Dysregulation

1

Note. Emotional Lability, Center for Neurologic Study- Lability Scale; Rumination, Rumination Scale; Lack of Cohesion, Revised
Dyadic Adjustment Scale; Social anxiety, Fear of Negative Evaluation; Global Dysregulation, Behavior Rating of Executive
Functions-Adult version.
*p < .05; **p < .01.

Table 3.5
Inter-correlations Among Measures of Neuropsychological Functioning
Measure

Poor “cool” EF

Poor “hot” EF

Visuo-spatial skills

Intelligence

Poor “cool” EF

1

.246

-.196

-.416*

1

-.147

-.338*

1

.573**

Poor “hot” EF
Visuo-spatial skills
Intelligence

1
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Note. Poor “cool” EF = Wisconsin Card Sorting Test; Poor “hot” EF = Iowa Gambling Test; Visuo-spatial skills = Judgment of Line
Orientation Test; Intelligence = Standard Progressive Matrices.
*p < .05; **p < .01.

Table 3.6
Inter-correlations Among Measures of Executive Functions and Self-Regulation
SR Domain

EF Measures

M (SD)

EF Measures (IQ Partialled)

Poor

Poor

“cool” EF

“hot” EF

Intelligence

Poor

Poor

“cool” EF

“hot” EF

18.68 (13.33) 10.59 (31.46) 38.51 (12.75)

Patients’ Ratings
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Emotional Lability

14.21 (5.45)

-.162

-.090

.116

-.126

-.054

Rumination

-15.09 (4.36)

.082

.047

-.078

.055

.0

Lack of Cohesion

8.02 (4.23)

.214

.151

-.064

.207

.137

Social Anxiety

28.63 (11.81)

.089

.016

.346*

.273

.151

-.057

-.090

-.081

-.100

-.125

Global Dysregulation 95.89 (17.95)
Caregivers’ Ratings
Emotional Lability

12.89 (4.47)

-.070

-.066

.188

.009

-.003

Rumination

-15.33 (4.10)

.354*

.045

-.407*

.222

-.108

Lack of Cohesion

6.19 (3.41)

-.155

-.212

.467**

.049

-.065

Social Anxiety

25.67 (12.12)

.137

.039

-.003

.150

.041

Global Dysregulation 88.30 (18.62)

.095

.006

-.160

.032

-.052

Note. Emotional Lability, Center for Neurologic Study- Lability Scale; Rumination, Rumination Scale; Lack of Cohesion, Revised
Dyadic Adjustment Scale; Social anxiety, Fear of Negative Evaluation Scale; Global Dysregulation, Behavior Rating of Executive
Functions-Adult version; Poor “cool” EF = Wisconsin Card Sorting Test; Poor “hot” EF = Iowa Gambling Test; Intelligence =
Standard Progressive Matrices.
*p < .05; **p < .01.
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Table 3.7
Inter-correlations Among Patients’ Physiological Functions and Self-Regulation
Patients’ Functioning
Self-Regulation Measure

HRV

A1C

M (SD)

1.51 (.42)

5.38 (.45)

Emotional Lability

-.344*

.054

Rumination

-.193

.258

Lack of Cohesion

.072

.000

Social Anxiety

-.195

.134

Global Dysregulation

-.190

.427**

Poor “cool” EF

.342*

.010

Poor “hot” EF

.199

.105

Emotional Lability

-.258

.150

Rumination

.261

.243

Lack of Cohesion

-.174

.205

Social Anxiety

-.140

.285

Global Dysregulation

-.077

.328*

Patient Ratings

Caregiver Ratings

Note. Caregivers did not complete the WCST and IGT tasks; Emotional Lability, Center
for Neurologic Study- Lability Scale; Rumination, Rumination Scale; Lack of Cohesion,
Revised Dyadic Adjustment Scale; Social anxiety, Fear of Negative Evaluation Scale;
Global Dysregulation, Behavior Rating of Executive Functions-Adult version; Poor
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“cool” EF = Wisconsin Card Sorting Test; Poor “hot” EF = Iowa Gambling Test;
Intelligence = Standard Progressive Matrices.
*p<.05; **p<.01
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Table 3.8
Inter-correlations Among Self-Regulation, Quality of Life, and Relationship Satisfaction
Measure

QOL
Patient

Patient

Caregiver

66.03 (15.99) 7.49 (1.46)

86.39 (16.02)

90.36 (12.40)

Emotional Lability

-.161

.110

-.224

.094

Rumination

-.349*

.005

-.023

-.013

Lack of Cohesion

-.403*

-.284

-.377*

-.083

Social Anxiety

-.500**

-.111

-.204

-.046

Global Dysregulation

-.200

-.057

.069

-.213

Poor “cool” EF

-.193

.117

-.205

.068

Poor “hot” EF

.276

.251

-.216

.346*

HRV

.078

.042

.022

.195

A1c

-.154

.314

-.086

-.103

M (SD)

Caregiver

Relationship Satisfaction

Patients’ Ratings
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Caregivers’ Ratings

Emotional Lability

-.159

-.221

-.225

-.181

Rumination

.018

-.281

-.205

-.029

Lack of Cohesion

-.214

.110

-.265

-.593**

Social Anxiety

-.140

-.114

-.306

-.289

Global Dysregulation

.151

-.131

-.250

-.174

*p<.05; **p<.01
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Figure3.1
Quadratic Relationship Between Patient and Caregiver Cohesion Ratings.
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Figure 3.2
Interaction of “Hot” and “Cool” EF in Predicting Patient Cohesion.
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Figure 3.3
Interaction of “Hot” and “Cool” EF in Predicting Caregiver Cohesion.
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Chapter Four
Discussion
ALS is increasingly viewed as a multi-system disorder accompanied by cognitive and
behavioral changes (Strong, 2001, 2008; Strong & Rosenfeld, 2003). However, an extensive
body of research has failed to clarify the nature or prevalence of these extra-motor symptoms
in ALS. The current study aimed to elucidate the prevalence and pattern of executive deficits
and behavioral dysregulation in patients with ALS.
Does the Pattern of Self-Regulatory Deficits in ALS Reflect a “Distinct” Disorder?
This research revealed that the scope of extra-motor impairment in ALS can be wide,
with deficits existing on a continuum such that some, but not all, patients evidence deficits in
self-regulatory abilities to effectively manage social relationships, emotions, and thought
processes. This informs research and clinical work with MND as self-regulatory deficits may
be part of the disease process for some patients.
Of particular interest in this study was convergence of self-regulatory deficits across
domains. Given research that executive control and behavioral self-regulation rely on a similar
resource, and that expenditure of this resource on one task can impair subsequent performance
on others, it was surprising that there was not a consistent pattern that emerged among
domains of self-regulation, “hot” and “cold” EF, and physiological regulation. Specifically,
deficits in EF were expected to correspond to behavioral deficits across domains of selfregulation as well as worse physiological functioning. Given that the IGT task, used as a
measure of “hot” EF, is a more context-dependent measure representative of “real-world”
situations, one might have expected to see stronger relationships among other measures of
“applied” behavioral self-regulation (i.e., social anxiety, rumination, emotional lability, and
global regulation). Conversely, “cool” EF was more highly correlated with various forms of
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behavior regulation in this sample. Specifically, more emotional lability (patient-rated) was
related to better “cool” EF (albeit not significantly), which is inconsistent with previous
research that emotional lability relates to worse “cool” EF (McCullagh et al., 1999). On the
other hand, “hot” EF was more highly correlated with patient and caregiver ratings of QOL
and relationship satisfaction. It is possible that “cool” EF most strongly relates to measures
assessing how people behave or act (emotional lability, dyadic cohesion) and “hot” EF relates
more closely to measure of how people feel (social anxiety, quality of life). Given the related,
yet distinct nature of the “hot” and “cool” components of EF, conceptualizing EF as a nonunitary construct is informative and important, especially for future studies. This may be
particularly true in ALS as deficits may influence important clinically important outcomes.
Who is Most Accurate in Rating Patient Behavior?
Even more, the pattern of inter-correlations among domains of SR differed depending
on who was rating patients’ self-regulatory abilities. Despite a lack of significant mean-level
differences between patients and caregivers, a clear tendency emerged for caregivers to rate
patients’ deficits more globally, such that caregiver ratings of patients’ self-regulatory abilities
aligned across domains (i.e., higher inter-correlations). Thus, caregiver ratings were indicative
of a more pervasive pattern of decline in self-regulatory capacity compared to patients.
Perhaps, it is caregivers who bear the burden of patients’ inability to regulate, therefore
resulting in more general or “accurate” ratings. Likewise, the impact of these deficits may be
more global for caregivers than patients. On the other hand, it is possible that caregivers are
most psychologically vulnerable to patients’ physical decline (compared to patients), and that
caregiver ratings reflect their own internal experience rather than the patients’ true abilities.
For example, caregivers of patients with ALS appear to suffer emotionally (as evidenced by
increased depression and perception of burden; Gauthier et al., 2007) and physically, as
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patients become more incapacitated. Thus, caregiver ratings of patients’ self-regulation could
better reflect their own quality of life, which has been shown to decline as ALS progresses.
Thus, the use of behaviorally specific measures may be most useful, especially when relying
on caregiver reports.
In general, patients appeared to perceive more variability (i.e., lower inter-correlations)
among self-regulatory abilities, such that self-regulatory deficits in one domain were not
suggestive of deficits across other domains. This discrepancy across domains (i.e., social,
thought process, emotions, cognitive) could be attributed to inaccurate perceptions of their
condition. Alternatively, patients could be more flexible and realistic than caregivers in
evaluating the specific deficits they experience. From a methodological standpoint, a lack of
strong or significant correlations could be an artifact of the measures used. Although the
scales used in this study generally had acceptable internal consistency, the construct validity of
these measures as measures of self-regulation is not fully established. Interestingly, the
measure that was most strongly and consistently related to other measures for both raters was
the BRIEF-A, which was designed as a measure of global regulation of behavior across a
variety of areas. It is possible that this measure best captures the variety of ways in which selfregulatory deficits are manifest. On the other hand, this measure did not highly correlate with
measures of “cool” or “hot” EF. Thus, the idea that EF and SR draw upon a common resource
but make unique contributions to behavior (Kaplan & Berman, 2010) is supported.
Taken together, there were few mean-level differences between patient and caregiver
ratings, but there was a clear difference in the pattern of inter-correlations between raters
across measures. Patient and caregiver agreement was highest when they rated the same
individual (i.e., the patient) and more overt/observable behavior (e.g., emotional lability), and
less when they expressed their own experience or rated the patients’ internal experience (e.g.,
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rumination). Of particular interest was the disagreement between patients and caregivers in
perceptions of relationship cohesion. Given the tendency of caregivers to interpret patients’
deficits as part of a pervasive pattern, and their susceptibility to decreased QOL, caregivers
were expected to perceive less cohesion in their relationship. However, patients tended to
perceive less cohesion. Patient-caregiver agreement was highest at the polar ends of the
spectrum (at lower scores and at higher scores). Even more, the effect of good “cool” EF
differed for patients and caregivers. For patients, good “cool” EF was associated with more
cohesion, only if there was also good “hot” EF. For caregivers, however, the relationship
between good “cool” EF and cohesion was strengthened by poor “hot” EF. Thus, the spectrum
of impairment appears to vary both quantitatively (how much impairment) and qualitatively
(what kind of impairment). Eliciting patient and caregiver reports may provide unique insights
into the nature of the deficits as well as the psychological experience of the patient-caregiver
dyads.
Is Self-Regulation Important for QOL?
A plethora of research has recently focused on QOL in ALS patients and their
caregivers. Consequently, the current research aimed to examine patient-caregiver agreement
regarding patients’ self-regulatory capacity, and the contribution of these perceptions on
quality of life. Previous literature consistently suggests that caregivers may be more
“vulnerable” to the progression of ALS, generally rating poorer QOL over the course of the
illness (Averill et al., 2007; Roach et al., 2009). However, caregiver QOL did not appear to be
influenced by caregiver perceptions of patients’ self-regulatory abilities. It is possible that the
more global factors (e.g., progression of time and disease) are most important to caregiver
QOL. Conversely, several domains of self-regulation were related to patient QOL.
Rumination, lack of cohesion, and social anxiety were linked to worse QOL for patients.
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Despite this evidence for the link between SR and QOL, research consistently suggests that
patients generally maintain QOL over the course of their illness (Robbins, Simmons, Bremer,
Walsh, & Fischer, 2001). In sum, although SR may be an important component of patients’
QOL, there are likely other important factors contributing to or preserving well-being in ALS
patients. Future research is needed to inform 1) the factors that contribute to declines in
caregiver well-being and 2) the “protective” factors regarding patient well-being, and enhance
interventions with ALS caregivers.
Are Physiological Resources Important?
This study lends support to the claim that glucose is an important component of
successful self-regulation (Benton et al., 1994; Gailliot, 2008; Gailliot & Baumeister, 2008;
Fairclough & Houston, 2004). Glycosolated hemoglobin (i.e., A1c) was significantly related
to patient and caregiver perceptions of global regulation. Thus, patients with better regulated
glucose were viewed and viewed themselves as more regulated on a global measure of selfregulation. Although non-significant, the general pattern that emerged was consistent with
expectations across domains, such that lower (e.g., better) A1c values were associated with
less emotional lability, less rumination, less social anxiety, and better “cool” and “hot” EF for
both patients and caregivers. Thus, although a causal mechanism is not established, it is
possible that measures reflective of glucose (tolerance or regulation) could serve to “mark”
those patients who are also likely to experience self-regulatory deficits.
However, the current study only partially converges with research linking vagallymediated HRV to prefrontal activity and SR (Brosschot et al., 2006; Thayer, 2007; Thayer,
Hansen, Saus-Rose, & Johnsen, 2009; Segerstrom & Solberg Nes, 2007). Higher resting HRV
was associated with less emotional lability according to patients (but not caregivers), which
converges with research linking emotional arousal to decreased (i.e., worse) HRV (Thayer et
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al., 2009). Similarly, patient and caregiver ratings of patients’ self-regulatory abilities across
other domains were consistently in the expected direction (albeit non-significant) with better
regulation linked to higher HRV. However, the pattern of associations among measures of EF
and HRV were unexpected, such that better “cool” EF was significantly associated with lower
(e.g., worse) baseline HRV in the current sample. A similar, non-significant pattern emerged
between “hot” EF and HRV. Taken together, this study suggests the mechanisms by which
HRV indexes the capacity for self-regulation in ALS patients may differ from other “healthy”
samples. If decreased HRV is in fact associated with the disease process of ALS (Oey et al.,
2002; Pisano et al., 1995), examining individual differences in HRV may be particularly
informative to self-regulatory processes. Alternatively, HRV could more dynamic in ALS
patients than in “healthy” samples (Sinnreich, Kark, Friedlander, Sapoznikov, & Luria, 1998),
which may suggest both theoretical and methodological adaptations for non-healthy samples.
Limitations
There are several limitations to the current research that should be acknowledged when
interpreting results and drawing conclusions. First, the sample of patients was both small and
varied. Although there was sufficient power to detect large effects, which had been previously
obtained in research on SR and EF, a larger sample would have increased the power to detect
small to moderate effects, which may be clinically important in ALS. Even more, a small
sample size necessitated careful selection of control variables to preserve degrees of freedom
in analyses (Breaugh, 2006; Lynam, Hoyle, & Newman, 2006; Segerstrom, 2009). A related
methodological concern is Type 1 error due to multiple comparisons. The current study did
not involve a correction (e.g., Bonferroni) for Type 1 error. Given the limited sample size, the
caution in relying on p-values in small samples, the risk of neglecting Type 2 error, and the
absence of theoretically guided a priori hypotheses (in many instances), preservation of power
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was a priority. The sample was also heterogeneous with regard to the site of MND and disease
onset. ALS and PLS patients were included in the sample given the similar conceptualizations
of the disorders as MND. Despite the relationship between ALS and PLS, they clearly have
different disease trajectories, with PLS progressing slower and being less fatal. Thus, it was
important to identify any disease-related differences the groups with regard to demographics or
variables of interest. This did not appear to influence the results of the current study, but there
are likely differences with regard to treatment implications and survival. Methodological
limitations should also be considered. To accommodate patients of varying functional levels,
measures that could be administered independent of speech and mobility were selected.
Therefore, the selection of measures was largely influenced by practical considerations with
this population, which is a common concern in the assessment of individuals with ALS. Thus,
it is possible that more valid or reliable measures (e.g., intelligence) would enhance confidence
in the current results. However, given the similar patterns of inter-correlations among
measures, it is unlikely that the substitution of any specific measure would substantially alter
the conclusions of this research. However, the need to establish and validate appropriate
assessment techniques for samples such as ALS patients (e.g., with limited mobility or
communicative abilities) is important.
Overall, ALS patients appear to be prone to a variety of self-regulatory deficits,
ranging from subtle to severe. However, this research suggests that both the quantity and
quality of impairment varies, and that the correlates of these deficits may be different for
patients and caregivers. However, adequate self-regulation across domains appears to
influence quality of life for patients and caregivers.

Copyright © Abbey R. Roach, 2010
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